Organizations engaged in research involving humans are required
to have proposed projects reviewed by a research ethics board
("REB"). Under the Tri-Council Policy Statement: Ethical Conduct for Research
Involving Humans (the
"Policy"), an organization is
responsible for establishing or appointing a REB to review the
ethical acceptability of research involving humans which is
conducted within its jurisdiction or under its auspices, including
approving, rejecting, proposing modifications to or terminating any
proposed or ongoing research.
There are many instances where organizations, due to their small
size and/or limited resources, seek support for this function from
other organizations that have established REBs. Under Article 6.1
of the Policy, organizations are permitted to appoint an external
REB to act as its REB of Record provided that there is an official
agreement between the parties.
Whether yours is the organization seeking to use the REB of
another party as its REB of Record or is the organization that is
willing to allow use of your REB by a third party, a formal
contract – an REB of Record of Agreement – is
required. When implementing an REB of Record Agreement,
parties should turn their minds to certain key risk management
considerations, including the following:
the availability of REB time and resources;
the willingness of REB volunteer members to assume additional
conflict of interest;
allocation of risk and responsibility; and
If you are engaging in an REB of Record arrangement as user or
provider, the Health Industry Group would be pleased to discuss
available options and strategies and provide support in
implementing your REB of Record Agreement.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
Effective September 1, 2016, the Disposition of Surplus Real Property Regulation to the Ontario Education Act was amended with the intention to reduce barriers to the formation of health and community hubs in Ontario.
This appeal relates to two generic drug submissions for two different products: exemestane and infliximab. Both submissions cross-referenced the submission of another generic company that had received a Notice of Compliance.
Two recent decisions from the Supreme Court of Canada directly affect Quebec's farm businesses by confirming La Financière Agricole du Québec's discretion in the administration of the farm income stabilization program...
On October 6, 2016, the Ontario Legislature reintroduced the Patients First Act, 2016 as Bill 41. Bill 41 is very similar to its predecessor, Bill 210, which was introduced in June 2016, but makes some important changes to the previous bill.
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).